Company Overview of Chlorion Pharma, Inc.
Chlorion Pharma, Inc., a biopharmaceutical company, develops therapeutics for the treatment of neuropathic pain and epilepsy. It offers CLP635, a molecule for the treatment of neuropathic pain and partial seizures. The company was founded in 2004 and is based in Laval, Canada.
500 Cartier Boulevard West
Laval, QC H7V 2B7
Founded in 2004
Key Executives for Chlorion Pharma, Inc.
Similar Private Companies By Industry
|2007262 Ontario, Inc.||Americas|
|2056273 Ontario, Inc.||Americas|
|AB BioPharma Inc.||Americas|
|AbCelex Technologies Inc.||Americas|
|AbCellera Biologics Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Chlorion Pharma, Inc., please visit www.chlorion.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.